Scientific article

Letter

English

Cotrimoxazole myelotoxicity in hematopoietic SCT recipients: time for reappraisal

ContributorsFontanet, Aline; Chalandon, Yves

; Roosnek, Eddy Emile; Mohty, Bilal; Passweg, Jakob

Published inBone marrow transplantation, vol. 46, no. 9, p. 1272-1273

Publication date2011

Keywords

Adolescent
Adult
Aged
Anti-Infective Agents/adverse effects/therapeutic use
Blood Platelets/physiology
Case-Control Studies
Female
Hematologic Diseases/blood/surgery
Hematopoietic Stem Cell Transplantation
Humans
Male
Middle Aged
Neutrophils/physiology
Trimethoprim-Sulfamethoxazole Combination/adverse effects/therapeutic use
Young Adult

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département de médecine

Research groups

Groupe Roosnek Eddy (hémato-oncologie) (19)

Funding

Swiss National Science Foundation - T cell and NK-cell immunity after hematopoietic stem cell transplantation and under inflammatory/anti-inflammatory conditions [127516]

Citation (ISO format)

FONTANET, Aline et al. Cotrimoxazole myelotoxicity in hematopoietic SCT recipients: time for reappraisal. In: Bone marrow transplantation, 2011, vol. 46, n° 9, p. 1272–1273. doi: 10.1038/bmt.2010.285

Article (Published version)

Identifiers

PID : unige:25202
DOI : 10.1038/bmt.2010.285
PMID : 21102496

Journal ISSN0268-3369

606views

0downloads

Creation02/11/2012 16:18:00

First validation02/11/2012 16:18:00

Update20/01/2025 09:56:39

Status update20/01/2025 09:56:39

Last indexation20/01/2025 10:10:46